June 09, 2026
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the pathophysiology of IgA nephropathy, focusing on the “four-hit” hypothesis. “The four-hit hypothesis ... is the working model for how we interpret the pathophysiology of this disease,” said Cravedi, assistant professor in the division of
June 09, 2026
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Otsuka touts new IgAN evidence as it seeks full approval for Voyxact

NKF Spring Clinical Meetings Highlight AI-Driven, Personalized Kidney Care

Otsuka showcases kidney drug data; Pfizer cuts an AI deal

AstraZeneca Reports Significant Proteinuria Reduction With Ultomiris In Rare Kidney Disease - AstraZeneca

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the…

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Jared R. Hassler, MD, discusses how the…

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Jared R. Hassler, MD, shares highlights…

Second agent targeting BAFF and APRIL appears effective in phase III trial

Otsuka's Voyxact preserved kidney function over 12 months in IgA nephropathy patients, new eGFR data show, as the company pursues…

Emerging data are reshaping how clinicians match patients to therapy